Kovai Medical Center & Hospital share price & results
- Jun 2026
- Sept 2026
NABH-accredited 2,000-bed multi-speciality hospital chain based in Coimbatore, Tamil Nadu.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 431 | +15.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 29.0 | +1.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 69.0 | +21.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | −7.2 pts | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. | |
| Free cash flow margin | −18.6 pts | Fiscal year | FY · period unavailable | Not in the analysed materials. No older figure is substituted. | |
| Revenue growth (YoY) | −2.7 pts | Trailing twelve months | TTM · period unavailable | Not in the analysed materials. No older figure is substituted. |
Price
Performance +125.8% 1Y
1Y: ₹2,576.65 on 25 Oct 2023 → ₹5,818.5. High ₹6,292 (10 Sept 2026), low ₹2,576.65 (25 Oct 2023).
- Previous close
- ₹5,757.5
- Market cap
- ₹6.4k Cr
- 52-week range
- ₹5,339 – ₹6,292
Overview
- Symbol
- NSE:KOVAI
- Sector
- Healthcare
- Exchange
- NSE
- Currency
- INR
What Kovai Medical Center & Hospital Limited does
Based on the company's own presentations, annual report and earnings calls.
Kovai Medical Center and Hospital Limited (KMCH) operates a multi-speciality hospital business centred in Coimbatore, Tamil Nadu, earning revenue from in-patient and out-patient clinical services across specialities such as cardiology, oncology, neurology, urology, ENT, gynaecology, paediatrics, gastroenterology and haematology, including kidney and liver transplant programs. The group grew from a 250-bed facility about 35 years ago into a 2,000-bed hospital and also runs the Sulur Multi-Speciality Hospital as a second campus. It has diversified into medical education, running an affiliated medical college alongside the hospital, and offers nursing, dietary and allied health sciences training.
- Bed capacity (main campus)
- 2,000 beds
- Hospital campuses
- Main Coimbatore campus plus the Sulur Multi-Speciality Hospital campus
- Accreditation
- NABH-accredited (National Accreditation Board for Hospitals and Healthcare Providers)
- Affiliated medical education institution
- Operates its own medical college alongside the hospital, plus nursing, dietary and allied health sciences courses
- Clinical specialities
- Multi-speciality care spanning cardiology, oncology, neurology, urology, ENT, gynaecology, paediatrics, gastroenterology and haematology, plus emergency care
- Transplant programs
- Kidney transplant and liver transplant programs
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2013 to Mar 2018).
Financials
What the filings say
Net profit, year on year: +21% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 344 | 355 | 357 | 374 | 392 | 407 | 414 | 431 |
| Expenses | 248 | 252 | 256 | 268 | 285 | 291 | 303 | 307 |
| Operating profit | 96 | 103 | 101 | 106 | 107 | 116 | 111 | 124 |
| Operating margin | 28.0% | 29.0% | 28.0% | 28.0% | 27.0% | 28.0% | 27.0% | 29.0% |
| Other income | 5 | 6 | 6 | 6 | 6 | 7 | 8 | 7 |
| Interest | 8 | 9 | 9 | 9 | 9 | 8 | 6 | 8 |
| Depreciation | 24 | 25 | 25 | 26 | 27 | 28 | 29 | 32 |
| Profit before tax | 67 | 75 | 74 | 76 | 78 | 87 | 84 | 92 |
| Tax rate | 25.0% | 23.0% | 26.0% | 25.0% | 24.0% | 25.0% | 25.0% | 25.0% |
| Net profit | 51 | 58 | 55 | 57 | 59 | 65 | 63 | 69 |
| EPS (₹ per share) | 46.32 | 52.82 | 49.99 | 52.30 | 53.79 | 59.42 | 57.89 | 63.14 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 1,019 | 1,220 | 1,371 | 1,587 |
| Expenses | 751 | 877 | 985 | 1,147 |
| Operating profit | 268 | 341 | 386 | 440 |
| Other income | 16 | 21 | 22 | 27 |
| Interest | 40 | 32 | 33 | 32 |
| Depreciation | 89 | 92 | 98 | 110 |
| Profit before tax | 155 | 238 | 277 | 325 |
| Net profit | 116 | 179 | 210 | 244 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 598 | 708 | 878 | 1,075 | 1,179 | 1,308 |
| Borrowings | 550 | 511 | 310 | 415 | 399 | 403 |
| Other liabilities | 184 | 209 | 240 | 299 | 328 | 345 |
| Total liabilities | 1,343 | 1,439 | 1,439 | 1,801 | 1,917 | 2,067 |
| Fixed assets | 1,085 | 1,088 | 1,118 | 1,283 | 1,286 | 1,474 |
| Capital work in progress | 5 | 23 | 39 | 154 | 224 | 135 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 |
| Other assets | 253 | 328 | 282 | 364 | 406 | 458 |
| Total assets | 1,343 | 1,439 | 1,439 | 1,801 | 1,917 | 2,067 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 186 | 262 | 263 | 344 | 335 | 362 |
| Cash from investing | -180 | -292 | -358 | -290 | -593 | -514 |
| Cash from financing | 38 | -119 | -86 | -243 | 62 | -58 |
| Net cash flow | 44 | -149 | -180 | -189 | -197 | -210 |
| Free cash flow | 5 | 163 | 136 | 206 | -18 | 111 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 7 | 8 | 8 | 5 | 8 | 9 |
| Inventory days | 19 | 19 | 18 | 17 | 15 | 17 |
| Days payable | 29 | 20 | 35 | 30 | 27 | 20 |
| Cash conversion cycle | -2 | 6 | -9 | -7 | -4 | 6 |
| Working capital days | -56 | -49 | -48 | -49 | -57 | -58 |
| Return on capital employed | 13.0% | 16.0% | 17.0% | 23.0% | 23.0% | 23.0% |
| Dividend payout | 4.0% | 6.0% | 9.0% | 6.0% | 5.0% | 7.0% |
Where revenue comes from
The businesses behind the company’s reported revenue.
Healthcare contributes 93.9% of reported segment revenue.
Quarter ended 30 Jun 2026 · Standalone
- Healthcare 93.9%
₹404.92 crore
- Education 6.1%
₹26.39 crore
| Business segment | Revenue · ₹ crore | Share |
|---|---|---|
| Healthcare | 404.92 | 93.9% |
| Education | 26.39 | 6.1% |
Share = segment revenue ÷ total segment revenue, before intersegment adjustments.
How these numbers add up
- Total segment revenue
- ₹431.31 crore
- Intersegment adjustment
- Not reported
- Net segment revenue
- ₹431.31 crore
Intersegment transactions are between the company’s own businesses. Net segment revenue can differ from income-statement revenue because reporting definitions differ.
Source: FinEdge · Last checked 19 Sept 2026. Reported segment names are kept as supplied.
What the price assumes
AttractiveTo justify its price of ₹5818, this stock must grow earnings at 17% every year for 7 years. Our analysis caps realistic growth at ~28%. At that growth it is worth ₹10150 — upside of 74%.
- Growth the price implies
- 17.3% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 28.1% a year
- net profit, FY23–FY26 · EPS 28.3%
- The gap
- -0.1 pp
- 74% downside if it only repeats history
Ownership
Who owns it
Promoters hold 56.54% as of Sept 2026; institutions added 0.04 pts since Jun 2026.
- Promoters 56.54%
- Foreign institutions 1.22%
- Domestic institutions 4.31%
- Public 37.94%
Who bought this quarter
since Jun 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- +11.51 pp 11.60% held
- Mutual fund +0.08 pp 1.62% held
The same filing shows 1 holder trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Sep 2026 filing
Every holder of Kovai Medical Center & Hospital Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| 36.97% | unchanged | |
| 11.60% | +11.51 pp | |
| 4.77% | unchanged | |
| Mutual fund | 1.62% | +0.08 pp |
| 1.37% | −0.07 pp | |
| 0.79% | unchanged | |
| 0.73% | unchanged | |
| 0.67% | unchanged | |
| 0.65% | unchanged | |
| 0.09% | unchanged | |
| 0.09% | unchanged | |
| 0.09% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Mutual funds in KOVAI
Filings to Sep 2026
1 new, 0 added, 0 trimmed, 0 sold out — net +0.01 L shares.
- Held by funds
- ₹1 Cr
- 1 schemes
- Biggest holder
- HDFC Retirement Fund - Hybrid-Debt Plan
- ₹1 Cr · 0.6% of that fund
| Scheme | Holding | Last month | Held since |
|---|---|---|---|
| HDFC Retirement Fund - Hybrid-Debt Plan HDFC Mutual Fund | ₹1 Cr | new | Sep '26 |
HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.
Mutual funds Sep 2026
0 added, 0 trimmed — net +1,500 shares
- Funds are sitting on
- -3%
- vs est. average cost
- Held by funds
- ₹1 Cr
- 1 schemes · ≈ 0.01% of the company
Your own record
Start an Inve Case for Kovai Medical Center & Hospital Limited
Free account: one company. Everything above stays public.
Write why you follow Kovai Medical Center & Hospital Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Healthcare companies
- MO
MOREPENLABMorepen Laboratories Limited - SU
SUPRIYASupriya Lifescience Limited - BL
BLISSGVSBliss GVS Pharma Limited - SA
SANOFISanofi India Limited - NE
NEPHROPLUSNephrocare Health Services Limited - SP
SPARCSun Pharma Advanced Research Company Limited - FD
FDCFDC Limited - SE
SENORESSenores Pharmaceuticals Limited
Learn to analyse Kovai Medical Center & Hospital Limited
Guides on how to read this kind of business and the numbers that matter.